Drini, Musa <br/><br/>
Hepatosplenic T-cell lymphoma following infliximab therapy for Crohn's disease.  [electronic resource] 

 -  The Medical journal of Australia  Oct 2008 
 - 464-5 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>0025-729X 
<br/><br/><label>Standard No.: </label>10.5694/j.1326-5377.2008.tb02124.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Monoclonal--adverse effects<br/>Crohn Disease--drug therapy<br/>Fatal Outcome<br/>Humans<br/>Immunologic Factors--adverse effects<br/>Infliximab<br/>Liver Neoplasms--chemically induced<br/>Lymphoma, T-Cell--chemically induced<br/>Male<br/>Splenic Neoplasms--chemically induced<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors